Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer.

Fulltext:
81120.pdf
Embargo:
until further notice
Size:
126.5Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2009Source
European Journal of Cancer, 45, 14, (2009), pp. 2444-6ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Laboratory of Genetic, Endocrine and Metabolic Diseases
Chemical Endocrinology
Journal title
European Journal of Cancer
Volume
vol. 45
Issue
iss. 14
Page start
p. 2444
Page end
p. 6
Subject
ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detectionThis item appears in the following Collection(s)
- Academic publications [227244]
- Electronic publications [108520]
- Faculty of Medical Sciences [86731]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.